Table 2.
Baseline antiretroviral drug use, CD4 cell count and HIV viral load among index participants in HPTN 074 (n = 502)
| Indonesian = 121 | Ukrainen = 187 | Vietnam n = 194 | Total n = 502 | p‐valuea | |||||
|---|---|---|---|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | N (%) | ||||||
| ART useb | |||||||||
| Currently on ART | 23 (19.0) | 3 (1.6) | 28 (14.4) | 54 (10.8) | <0.01 | ||||
| Previously on ART | 14 (11.6) | 28 (15.0) | 4 (2.1) | 46 (9.2) | |||||
| ART naïve | 84 (69.4) | 156 (83.4) | 162 (83.5) | 402 (80.1) | |||||
| Median | (IQR) | Median | (IQR) | Median | (IQR) | Median | (IQR) | ||
| Years since HIV diagnosis | 1.50 | (0.02,6.91) | 4.16 | (1.87,9.37) | 0.09 | (0.06,0.45) | 1.41 | (0.07,6.41) | <0.01 |
| HIV‐1 viral load (log10 copies/mL) | 4.53 | (4.18, 4.94) | 4.54 | (3.83, 5.07) | 4.61 | (4.05, 4.96) | 4.56 | (3.99, 4.99) | 0.99 |
| CD4 cell count (cells/μL) | 271 | (147, 418) | 310 | (178, 465) | 314 | (187, 492) | 293 | (166, 463) | 0.09 |
IQR: interquartile range; ART: antiretroviral therapy.
a
Pearson's chi‐square test was performed for ART use and one‐way ANOVA was used for continuous measures.
b
Based on self‐report.